NanoSpectrometer Biomarker Discovery and Confirmation Study

Stopped early

Conditions studied: Lung Cancer

In brief

This study will evaluate exhaled volatile organic compounds (VOC's) in the breath of participants with stage 1 lung cancer, their house-mates, and matched controls. The goal of the study is to identify VOC fingerprints that are only detectable in those with stage 1 lung cancer.

Key facts

Study ID

NCT03275688

Run by

Johns Hopkins University

People needed

332

Starts

2017-09-05

Expected to finish

2020-07-06

Last updated by the study team

2020-07-22

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Adults age 18 and over with diagnosed Stage 1 Lung Cancer (cases)
• Adults age 18 and over without Lung cancer (type 1 controls)
• Adults age 18 and over who live in the same environment as the cases (type 2 controls)
• Exclusion Criteria N/A

Where it is running

• Johns Hopkins Hospital — Baltimore, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.